

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.64097347 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.64097347 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.52044615 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.27777002 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.27777002 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.27777002 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.27777002 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.27777002 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.27777002 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.27450250 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95515818 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.77040727 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.77040727 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57539906 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 3.52366038 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42873058 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.39419967 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 3.34843072 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.34275109 |
| 20 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.27820055 |
| 21 | detection of other organism (GO:0098543) | 3.24824271 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.19927514 |
| 23 | germinal center formation (GO:0002467) | 3.16626174 |
| 24 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.15281390 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12222507 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05248070 |
| 27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02051077 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00903786 |
| 29 | detection of bacterium (GO:0016045) | 3.00712268 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.95629966 |
| 31 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94327642 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94213356 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92808383 |
| 34 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92676698 |
| 35 | positive regulation of type 2 immune response (GO:0002830) | 2.87822639 |
| 36 | regulation of vitamin metabolic process (GO:0030656) | 2.87037889 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85697618 |
| 38 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.85360497 |
| 39 | regulation of type 2 immune response (GO:0002828) | 2.85211256 |
| 40 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84050415 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 2.84048885 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.81804222 |
| 43 | response to host immune response (GO:0052572) | 2.81804222 |
| 44 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81390210 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 2.79050467 |
| 46 | response to type I interferon (GO:0034340) | 2.78446275 |
| 47 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77899916 |
| 48 | positive regulation of interferon-beta production (GO:0032728) | 2.75909926 |
| 49 | negative regulation of lipid storage (GO:0010888) | 2.73990548 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 2.73544462 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71492043 |
| 52 | response to host (GO:0075136) | 2.71492043 |
| 53 | response to host defenses (GO:0052200) | 2.71492043 |
| 54 | leukocyte aggregation (GO:0070486) | 2.70914699 |
| 55 | cellular response to type I interferon (GO:0071357) | 2.70123669 |
| 56 | type I interferon signaling pathway (GO:0060337) | 2.70123669 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.69982833 |
| 58 | regulation of cholesterol storage (GO:0010885) | 2.67943181 |
| 59 | cellular extravasation (GO:0045123) | 2.67638749 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66590626 |
| 61 | detection of molecule of bacterial origin (GO:0032490) | 2.65573767 |
| 62 | B cell mediated immunity (GO:0019724) | 2.64200951 |
| 63 | response to peptidoglycan (GO:0032494) | 2.64176215 |
| 64 | negative regulation of type 2 immune response (GO:0002829) | 2.63386784 |
| 65 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.62202736 |
| 66 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.60860800 |
| 67 | response to muramyl dipeptide (GO:0032495) | 2.60858905 |
| 68 | detection of biotic stimulus (GO:0009595) | 2.60212247 |
| 69 | respiratory burst (GO:0045730) | 2.59241717 |
| 70 | regulation of podosome assembly (GO:0071801) | 2.57896070 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 2.57247831 |
| 72 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.56882559 |
| 73 | regulation of tolerance induction (GO:0002643) | 2.56764809 |
| 74 | apoptotic cell clearance (GO:0043277) | 2.56629137 |
| 75 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56077086 |
| 76 | neutrophil activation (GO:0042119) | 2.55397011 |
| 77 | pinocytosis (GO:0006907) | 2.53652561 |
| 78 | regulation of RIG-I signaling pathway (GO:0039535) | 2.53632766 |
| 79 | positive thymic T cell selection (GO:0045059) | 2.53180481 |
| 80 | low-density lipoprotein particle clearance (GO:0034383) | 2.51794230 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51453437 |
| 82 | regulation of antigen processing and presentation (GO:0002577) | 2.51354505 |
| 83 | protein localization to endosome (GO:0036010) | 2.51116589 |
| 84 | regulation of B cell differentiation (GO:0045577) | 2.50781959 |
| 85 | granulocyte activation (GO:0036230) | 2.48900268 |
| 86 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.48457983 |
| 87 | regulation of response to interferon-gamma (GO:0060330) | 2.48089329 |
| 88 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47387476 |
| 89 | myeloid dendritic cell activation (GO:0001773) | 2.46969687 |
| 90 | hepatocyte apoptotic process (GO:0097284) | 2.43833470 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.43717181 |
| 92 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.43060966 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 2.42589222 |
| 94 | regulation of chronic inflammatory response (GO:0002676) | 2.41594666 |
| 95 | response to interferon-alpha (GO:0035455) | 2.40730321 |
| 96 | negative regulation of viral genome replication (GO:0045071) | 2.39901886 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 2.38962171 |
| 98 | dendritic cell chemotaxis (GO:0002407) | 2.38095867 |
| 99 | myeloid cell activation involved in immune response (GO:0002275) | 2.37544495 |
| 100 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.37290432 |
| 101 | growth hormone receptor signaling pathway (GO:0060396) | 2.37235975 |
| 102 | leukocyte cell-cell adhesion (GO:0007159) | 2.37203116 |
| 103 | defense response to protozoan (GO:0042832) | 2.37164630 |
| 104 | cellular response to virus (GO:0098586) | 2.36326609 |
| 105 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.36133244 |
| 106 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.35756537 |
| 107 | cellular response to interferon-alpha (GO:0035457) | 2.35448416 |
| 108 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.35423291 |
| 109 | response to protozoan (GO:0001562) | 2.35312508 |
| 110 | regulation of leukocyte degranulation (GO:0043300) | 2.35241324 |
| 111 | cellular response to interferon-gamma (GO:0071346) | 2.35177746 |
| 112 | positive regulation of tolerance induction (GO:0002645) | 2.34513211 |
| 113 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.34192647 |
| 114 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.34000935 |
| 115 | protein carboxylation (GO:0018214) | 2.33953532 |
| 116 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.33953532 |
| 117 | natural killer cell mediated immunity (GO:0002228) | 2.32831433 |
| 118 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.32831433 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31046612 |
| 120 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.29990870 |
| 121 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.29773577 |
| 122 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29459495 |
| 123 | macrophage activation (GO:0042116) | 2.28090817 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.27190811 |
| 125 | regulation of natural killer cell differentiation (GO:0032823) | 2.26624650 |
| 126 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.26179490 |
| 127 | negative regulation of interleukin-12 production (GO:0032695) | 2.24992558 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.22745702 |
| 129 | positive regulation of humoral immune response (GO:0002922) | 2.21985181 |
| 130 | positive regulation of antigen processing and presentation (GO:0002579) | 2.21983834 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.20199411 |
| 132 | positive regulation of isotype switching (GO:0045830) | 2.20147641 |
| 133 | T cell migration (GO:0072678) | 2.20121105 |
| 134 | response to laminar fluid shear stress (GO:0034616) | 2.20082351 |
| 135 | dendritic cell differentiation (GO:0097028) | 2.18264290 |
| 136 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.17952222 |
| 137 | positive regulation of B cell mediated immunity (GO:0002714) | 2.17667592 |
| 138 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.17667592 |
| 139 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.17392969 |
| 140 | regulation of interferon-beta production (GO:0032648) | 2.17281444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.83385399 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.85353505 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66009271 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.57804135 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.51813965 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.40596896 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.18127049 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00551335 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94341285 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92033907 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82306003 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81172144 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78389066 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78079508 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71231845 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.58130144 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50998792 |
| 18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.41098133 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39520301 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38944108 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30242181 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28893980 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16386412 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15917314 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10144212 |
| 26 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05365540 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.99997919 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98136281 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95282008 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.95133385 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.94585859 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92937224 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.84755894 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84708998 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.84329637 |
| 36 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82942841 |
| 37 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82194325 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.80594249 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77005333 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.76837414 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74328950 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72730620 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71791619 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69980614 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66599888 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66528632 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63038257 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61709497 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60013269 |
| 50 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54752742 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53493663 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53074572 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52796885 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45967105 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44700275 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43926433 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37769757 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30672095 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29510678 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29338093 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28435125 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28023259 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27621467 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26405796 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26349813 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25638665 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25346726 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23795796 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22472153 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21077719 |
| 71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20845751 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20687201 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20208059 |
| 74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17268534 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14850571 |
| 76 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14189937 |
| 77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13493349 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12530915 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12314601 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12091896 |
| 81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11450688 |
| 82 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11314528 |
| 83 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10883190 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10537256 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09668106 |
| 86 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09115985 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07987921 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07823608 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05626987 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05397648 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04888261 |
| 92 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03965942 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02309201 |
| 94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01559842 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01559842 |
| 96 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00539457 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00217412 |
| 98 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97970659 |
| 99 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97197475 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96939250 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96134245 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 0.96026376 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95535016 |
| 104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95329076 |
| 105 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95023712 |
| 106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94979743 |
| 107 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94537081 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93862731 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93809392 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93670921 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93315585 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93184353 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92725738 |
| 114 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92240763 |
| 115 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.91822715 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91441582 |
| 117 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.90711689 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90321150 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89113898 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87736004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.02981618 |
| 2 | MP0003436_decreased_susceptibility_to | 2.74142540 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.69619889 |
| 4 | MP0003724_increased_susceptibility_to | 2.54417387 |
| 5 | MP0003303_peritoneal_inflammation | 2.35146983 |
| 6 | MP0009785_altered_susceptibility_to | 2.32859751 |
| 7 | MP0000685_abnormal_immune_system | 2.26181319 |
| 8 | MP0005451_abnormal_body_composition | 2.17165182 |
| 9 | MP0002419_abnormal_innate_immunity | 2.15527068 |
| 10 | MP0001790_abnormal_immune_system | 2.07810986 |
| 11 | MP0005387_immune_system_phenotype | 2.07810986 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.06483234 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.04420809 |
| 14 | MP0005025_abnormal_response_to | 2.03241331 |
| 15 | MP0001800_abnormal_humoral_immune | 1.98797351 |
| 16 | MP0005360_urolithiasis | 1.98512369 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.96815267 |
| 18 | MP0002452_abnormal_antigen_presenting | 1.92449454 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.88334541 |
| 20 | MP0005464_abnormal_platelet_physiology | 1.87860282 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.87837477 |
| 22 | MP0002723_abnormal_immune_serum | 1.81552726 |
| 23 | MP0002006_tumorigenesis | 1.79635787 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.79631853 |
| 25 | MP0005671_abnormal_response_to | 1.76474442 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.74981901 |
| 27 | MP0004947_skin_inflammation | 1.71150415 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.68686243 |
| 29 | MP0001819_abnormal_immune_cell | 1.68329366 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.67055557 |
| 31 | MP0006082_CNS_inflammation | 1.65121083 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.62378785 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.61952002 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.61292318 |
| 35 | MP0009840_abnormal_foam_cell | 1.60113463 |
| 36 | MP0002405_respiratory_system_inflammati | 1.57934772 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.57154063 |
| 38 | MP0005365_abnormal_bile_salt | 1.53491003 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.53214958 |
| 40 | MP0001853_heart_inflammation | 1.50744129 |
| 41 | MP0009278_abnormal_bone_marrow | 1.49132576 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.47472310 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.45651990 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.45213975 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.45213975 |
| 46 | MP0008260_abnormal_autophagy | 1.41593153 |
| 47 | MP0001873_stomach_inflammation | 1.40595403 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.40313111 |
| 49 | MP0008469_abnormal_protein_level | 1.38154968 |
| 50 | MP0008004_abnormal_stomach_pH | 1.37676873 |
| 51 | * MP0002398_abnormal_bone_marrow | 1.37294558 |
| 52 | MP0003252_abnormal_bile_duct | 1.35975914 |
| 53 | MP0005164_abnormal_response_to | 1.34152285 |
| 54 | MP0003448_altered_tumor_morphology | 1.33849954 |
| 55 | * MP0000716_abnormal_immune_system | 1.33754033 |
| 56 | MP0010307_abnormal_tumor_latency | 1.32989594 |
| 57 | MP0003828_pulmonary_edema | 1.31375941 |
| 58 | MP0009764_decreased_sensitivity_to | 1.31343686 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.31286205 |
| 60 | MP0005085_abnormal_gallbladder_physiolo | 1.28563732 |
| 61 | MP0006054_spinal_hemorrhage | 1.28136623 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.25410409 |
| 63 | * MP0000689_abnormal_spleen_morphology | 1.24809417 |
| 64 | MP0000858_altered_metastatic_potential | 1.24565069 |
| 65 | MP0000604_amyloidosis | 1.24548787 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.22977295 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.22011025 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.20253334 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.20076491 |
| 70 | MP0000609_abnormal_liver_physiology | 1.19272545 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.19087902 |
| 72 | * MP0002722_abnormal_immune_system | 1.16971921 |
| 73 | MP0004883_abnormal_blood_vessel | 1.14809322 |
| 74 | * MP0002429_abnormal_blood_cell | 1.14569326 |
| 75 | MP0003690_abnormal_glial_cell | 1.14076313 |
| 76 | MP0005023_abnormal_wound_healing | 1.11009011 |
| 77 | MP0004510_myositis | 1.10621167 |
| 78 | MP0000569_abnormal_digit_pigmentation | 1.10540542 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.10273300 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.07417962 |
| 81 | MP0002933_joint_inflammation | 1.05102719 |
| 82 | MP0010329_abnormal_lipoprotein_level | 1.03550448 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 1.02719739 |
| 84 | MP0009763_increased_sensitivity_to | 1.02285569 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.01302183 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.97750047 |
| 87 | MP0000343_altered_response_to | 0.97395421 |
| 88 | MP0000490_abnormal_crypts_of | 0.97183948 |
| 89 | MP0001851_eye_inflammation | 0.97105096 |
| 90 | MP0003866_abnormal_defecation | 0.95867868 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.94846678 |
| 92 | MP0002254_reproductive_system_inflammat | 0.94340370 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92868645 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.92411674 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.92245698 |
| 96 | MP0005310_abnormal_salivary_gland | 0.92158175 |
| 97 | MP0001542_abnormal_bone_strength | 0.90782083 |
| 98 | MP0003091_abnormal_cell_migration | 0.90493596 |
| 99 | MP0000598_abnormal_liver_morphology | 0.90463381 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.86930751 |
| 101 | MP0005165_increased_susceptibility_to | 0.86481893 |
| 102 | MP0003186_abnormal_redox_activity | 0.86418063 |
| 103 | MP0005390_skeleton_phenotype | 0.86109048 |
| 104 | MP0001666_abnormal_nutrient_absorption | 0.85960158 |
| 105 | MP0001958_emphysema | 0.85709200 |
| 106 | * MP0000703_abnormal_thymus_morphology | 0.84140598 |
| 107 | MP0003279_aneurysm | 0.83172362 |
| 108 | MP0000249_abnormal_blood_vessel | 0.82933732 |
| 109 | MP0005166_decreased_susceptibility_to | 0.81827948 |
| 110 | MP0002928_abnormal_bile_duct | 0.81703907 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.81332025 |
| 112 | MP0003075_altered_response_to | 0.81303448 |
| 113 | MP0002060_abnormal_skin_morphology | 0.80366624 |
| 114 | MP0005083_abnormal_biliary_tract | 0.80068601 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.79359109 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.78007140 |
| 117 | MP0001663_abnormal_digestive_system | 0.76092010 |
| 118 | MP0003795_abnormal_bone_structure | 0.76055670 |
| 119 | MP0003045_fibrosis | 0.75208204 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.69808006 |
| 121 | MP0005275_abnormal_skin_tensile | 0.68589611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.66587970 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.18989132 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.07125598 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.00283071 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.00283071 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.00283071 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99635353 |
| 8 | Myocardial infarction (HP:0001658) | 3.46760703 |
| 9 | Myositis (HP:0100614) | 3.41281057 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.37653078 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.35682459 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.03549545 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.02316018 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.00534429 |
| 15 | Gingival bleeding (HP:0000225) | 2.90818259 |
| 16 | Orchitis (HP:0100796) | 2.89327715 |
| 17 | Abnormality of macrophages (HP:0004311) | 2.86990429 |
| 18 | Recurrent viral infections (HP:0004429) | 2.86964219 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 2.85460644 |
| 20 | Spontaneous hematomas (HP:0007420) | 2.83975842 |
| 21 | Pustule (HP:0200039) | 2.83496990 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 2.80124578 |
| 23 | Hematochezia (HP:0002573) | 2.79578327 |
| 24 | Loss of speech (HP:0002371) | 2.77149233 |
| 25 | Joint hemorrhage (HP:0005261) | 2.75779782 |
| 26 | Recurrent skin infections (HP:0001581) | 2.72795289 |
| 27 | Osteolytic defects of the hand bones (HP:0009699) | 2.70625680 |
| 28 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.70625680 |
| 29 | Periodontitis (HP:0000704) | 2.68071896 |
| 30 | Gingivitis (HP:0000230) | 2.65348393 |
| 31 | Arterial thrombosis (HP:0004420) | 2.63161784 |
| 32 | Thrombocytosis (HP:0001894) | 2.58148522 |
| 33 | Amyloidosis (HP:0011034) | 2.57663182 |
| 34 | Deep venous thrombosis (HP:0002625) | 2.57323441 |
| 35 | Complement deficiency (HP:0004431) | 2.55724511 |
| 36 | Peritonitis (HP:0002586) | 2.55040787 |
| 37 | Vasculitis (HP:0002633) | 2.52574138 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.51408034 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.45802846 |
| 40 | Esophageal varix (HP:0002040) | 2.44412820 |
| 41 | Cellulitis (HP:0100658) | 2.44144354 |
| 42 | Epistaxis (HP:0000421) | 2.42189055 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 2.40378529 |
| 44 | Abnormality of complement system (HP:0005339) | 2.35262921 |
| 45 | Xanthomatosis (HP:0000991) | 2.35252379 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.32667118 |
| 47 | Optic neuritis (HP:0100653) | 2.32667118 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.28037894 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.27167191 |
| 50 | Abnormal platelet volume (HP:0011876) | 2.25415129 |
| 51 | Vertebral compression fractures (HP:0002953) | 2.24496926 |
| 52 | Impaired platelet aggregation (HP:0003540) | 2.22306907 |
| 53 | Abnormal platelet function (HP:0011869) | 2.22306907 |
| 54 | Glomerulonephritis (HP:0000099) | 2.22293689 |
| 55 | Increased IgM level (HP:0003496) | 2.17745209 |
| 56 | Gangrene (HP:0100758) | 2.17720635 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.16710810 |
| 58 | Colitis (HP:0002583) | 2.16119242 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.15646932 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.15495662 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.14639300 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.14490311 |
| 63 | Stomatitis (HP:0010280) | 2.13954855 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.13712312 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13712312 |
| 66 | Chronic otitis media (HP:0000389) | 2.13475725 |
| 67 | Neurofibrillary tangles (HP:0002185) | 2.13092031 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.10828815 |
| 69 | Osteomyelitis (HP:0002754) | 2.09392128 |
| 70 | Thrombophlebitis (HP:0004418) | 2.08527440 |
| 71 | Increased mean platelet volume (HP:0011877) | 2.08308689 |
| 72 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.07726313 |
| 73 | Malnutrition (HP:0004395) | 2.07290316 |
| 74 | T lymphocytopenia (HP:0005403) | 2.07108715 |
| 75 | Tetraparesis (HP:0002273) | 2.06150052 |
| 76 | Menorrhagia (HP:0000132) | 2.04786375 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.03930022 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.03573189 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.03389245 |
| 80 | Joint swelling (HP:0001386) | 2.02602306 |
| 81 | Increased serum ferritin (HP:0003281) | 2.02159107 |
| 82 | Abnormality of T cells (HP:0002843) | 2.02107274 |
| 83 | Leukocytosis (HP:0001974) | 2.01938057 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01368812 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01368812 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01368812 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01180965 |
| 88 | Thin bony cortex (HP:0002753) | 2.00451215 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00302239 |
| 90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00302239 |
| 91 | Meningitis (HP:0001287) | 2.00239477 |
| 92 | Purpura (HP:0000979) | 1.99584348 |
| 93 | Glomerulopathy (HP:0100820) | 1.97624639 |
| 94 | Spondylolisthesis (HP:0003302) | 1.97414521 |
| 95 | Disinhibition (HP:0000734) | 1.96495115 |
| 96 | Nephritis (HP:0000123) | 1.96249121 |
| 97 | Pulmonary embolism (HP:0002204) | 1.96077263 |
| 98 | Axonal loss (HP:0003447) | 1.95820606 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95445453 |
| 100 | Basal ganglia calcification (HP:0002135) | 1.94678534 |
| 101 | Hemoptysis (HP:0002105) | 1.94145875 |
| 102 | IgM deficiency (HP:0002850) | 1.93887701 |
| 103 | Urticaria (HP:0001025) | 1.93728527 |
| 104 | Cervical subluxation (HP:0003308) | 1.93399099 |
| 105 | Abnormality of the pericardium (HP:0001697) | 1.92681181 |
| 106 | Recurrent bronchitis (HP:0002837) | 1.92088895 |
| 107 | Obstructive lung disease (HP:0006536) | 1.90158118 |
| 108 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90158118 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88715825 |
| 110 | Chronic diarrhea (HP:0002028) | 1.88412656 |
| 111 | Nasal polyposis (HP:0100582) | 1.88368692 |
| 112 | Nuclear cataract (HP:0100018) | 1.88312062 |
| 113 | Protrusio acetabuli (HP:0003179) | 1.87712071 |
| 114 | Polycythemia (HP:0001901) | 1.87503242 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 1.86840262 |
| 116 | Hemorrhage of the eye (HP:0011885) | 1.84378419 |
| 117 | Acne (HP:0001061) | 1.84377534 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 1.84298669 |
| 119 | Intrahepatic cholestasis (HP:0001406) | 1.83961598 |
| 120 | Abnormality of the fingertips (HP:0001211) | 1.83709775 |
| 121 | Encephalitis (HP:0002383) | 1.83579810 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.82665080 |
| 123 | Increased IgE level (HP:0003212) | 1.82642674 |
| 124 | Aortic aneurysm (HP:0004942) | 1.82161484 |
| 125 | Chest pain (HP:0100749) | 1.81759619 |
| 126 | Abnormality of the pleura (HP:0002103) | 1.80426371 |
| 127 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79505959 |
| 128 | Anorexia (HP:0002039) | 1.78522967 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 1.78267524 |
| 130 | Dilatation of the ascending aorta (HP:0005111) | 1.77968861 |
| 131 | Emphysema (HP:0002097) | 1.76300140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.11339694 |
| 2 | MAP3K14 | 3.04298774 |
| 3 | MAP4K1 | 2.85610398 |
| 4 | ERN1 | 2.84232355 |
| 5 | TBK1 | 2.57787983 |
| 6 | TYK2 | 2.54965492 |
| 7 | JAK3 | 2.45395187 |
| 8 | FGFR4 | 2.16697732 |
| 9 | TRIB3 | 2.14798502 |
| 10 | IKBKE | 2.10496311 |
| 11 | TAOK3 | 2.04522857 |
| 12 | STK10 | 2.02765286 |
| 13 | KIT | 2.00962093 |
| 14 | IRAK4 | 2.00515191 |
| 15 | FLT3 | 1.87203515 |
| 16 | PKN2 | 1.85903531 |
| 17 | JAK1 | 1.82840071 |
| 18 | TGFBR2 | 1.80223164 |
| 19 | ZAP70 | 1.78745863 |
| 20 | TAOK2 | 1.75209461 |
| 21 | TXK | 1.73160038 |
| 22 | IKBKB | 1.65766274 |
| 23 | MAP2K3 | 1.65693499 |
| 24 | BMPR2 | 1.65596795 |
| 25 | EPHB1 | 1.63387558 |
| 26 | GRK7 | 1.58682079 |
| 27 | CSK | 1.57617902 |
| 28 | MAP3K10 | 1.45318365 |
| 29 | TEC | 1.43252268 |
| 30 | BTK | 1.41500016 |
| 31 | CHUK | 1.40658287 |
| 32 | PTK6 | 1.40273920 |
| 33 | DDR2 | 1.39383257 |
| 34 | FGFR3 | 1.37229441 |
| 35 | CDC42BPA | 1.36203118 |
| 36 | MAP3K3 | 1.35829238 |
| 37 | CSF1R | 1.34667207 |
| 38 | EPHA3 | 1.32826970 |
| 39 | BLK | 1.29321680 |
| 40 | TTN | 1.28507550 |
| 41 | NEK9 | 1.27899145 |
| 42 | ITK | 1.27483645 |
| 43 | PIM2 | 1.25208155 |
| 44 | IRAK3 | 1.25146482 |
| 45 | FGR | 1.21481270 |
| 46 | LRRK2 | 1.21317767 |
| 47 | EEF2K | 1.20554043 |
| 48 | MAP3K1 | 1.20134169 |
| 49 | PIM1 | 1.19936426 |
| 50 | KDR | 1.18334989 |
| 51 | RPS6KA4 | 1.17887508 |
| 52 | SIK1 | 1.11817626 |
| 53 | JAK2 | 1.11235246 |
| 54 | STK3 | 1.09842661 |
| 55 | MATK | 1.09703742 |
| 56 | CAMK1D | 1.08835492 |
| 57 | MOS | 1.07156722 |
| 58 | HCK | 1.06431983 |
| 59 | RIPK4 | 1.04212970 |
| 60 | LCK | 0.99679292 |
| 61 | NLK | 0.97653549 |
| 62 | CDK6 | 0.97620486 |
| 63 | SIK3 | 0.97377684 |
| 64 | MAP3K13 | 0.96479381 |
| 65 | CDK12 | 0.96158808 |
| 66 | NME2 | 0.95942074 |
| 67 | GRK6 | 0.94144770 |
| 68 | SYK | 0.91979379 |
| 69 | PDPK1 | 0.89370377 |
| 70 | FRK | 0.89003757 |
| 71 | SMG1 | 0.88509018 |
| 72 | TGFBR1 | 0.87698140 |
| 73 | TESK2 | 0.87452809 |
| 74 | TRPM7 | 0.83743184 |
| 75 | ICK | 0.81953822 |
| 76 | MARK3 | 0.79075615 |
| 77 | KSR2 | 0.79064358 |
| 78 | LYN | 0.76259982 |
| 79 | SCYL2 | 0.75632172 |
| 80 | BMX | 0.74720946 |
| 81 | LATS1 | 0.72421282 |
| 82 | IRAK1 | 0.72072336 |
| 83 | IRAK2 | 0.70924282 |
| 84 | PAK4 | 0.70506507 |
| 85 | PIK3CG | 0.68020975 |
| 86 | PRKD2 | 0.67677939 |
| 87 | PDGFRB | 0.67148674 |
| 88 | MARK2 | 0.66686638 |
| 89 | MAP3K2 | 0.66480996 |
| 90 | MST1R | 0.65383372 |
| 91 | CDK4 | 0.64680866 |
| 92 | STK4 | 0.64649652 |
| 93 | MAPK7 | 0.61571270 |
| 94 | BRSK2 | 0.61374646 |
| 95 | MAP3K6 | 0.60409566 |
| 96 | MAPK11 | 0.58826493 |
| 97 | PDK1 | 0.56754054 |
| 98 | TAOK1 | 0.56724541 |
| 99 | MAP3K11 | 0.56169328 |
| 100 | MST4 | 0.56137674 |
| 101 | PRKG2 | 0.55297912 |
| 102 | ABL1 | 0.54888185 |
| 103 | MAP3K8 | 0.54461473 |
| 104 | PDGFRA | 0.53932282 |
| 105 | YES1 | 0.53753696 |
| 106 | HIPK2 | 0.53708949 |
| 107 | NUAK1 | 0.53184418 |
| 108 | STK38 | 0.52931433 |
| 109 | EGFR | 0.50282144 |
| 110 | EPHA2 | 0.49811661 |
| 111 | CLK1 | 0.47675139 |
| 112 | PTK2 | 0.47646238 |
| 113 | PAK2 | 0.45312800 |
| 114 | TIE1 | 0.44705514 |
| 115 | ABL2 | 0.43661693 |
| 116 | RET | 0.42721769 |
| 117 | SGK3 | 0.41313131 |
| 118 | TESK1 | 0.41242371 |
| 119 | MAPK15 | 0.41070949 |
| 120 | GSK3A | 0.40421537 |
| 121 | RPS6KL1 | 0.40414065 |
| 122 | RPS6KC1 | 0.40414065 |
| 123 | MAPKAPK2 | 0.40248471 |
| 124 | PRKAA2 | 0.39788652 |
| 125 | MELK | 0.39704213 |
| 126 | MAP3K5 | 0.39693471 |
| 127 | CDK9 | 0.38844484 |
| 128 | IGF1R | 0.38636705 |
| 129 | FES | 0.37985000 |
| 130 | CAMK1G | 0.37895609 |
| 131 | DYRK1B | 0.36341388 |
| 132 | MTOR | 0.34954526 |
| 133 | NEK2 | 0.33395684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.89846923 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64122608 |
| 3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.16024468 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02816617 |
| 5 | Malaria_Homo sapiens_hsa05144 | 1.90693942 |
| 6 | Measles_Homo sapiens_hsa05162 | 1.90068918 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89478998 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86771698 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85909650 |
| 10 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81831465 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.78266015 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.74715578 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73751689 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73196944 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.64670192 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58667398 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55108261 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54861099 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51899536 |
| 20 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51722185 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.47754182 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.47476116 |
| 23 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.45785989 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.45412306 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42122785 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41151216 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35209698 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33917222 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33902592 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.32153786 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.31532296 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23530438 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19753024 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.17712655 |
| 35 | * Apoptosis_Homo sapiens_hsa04210 | 1.15255685 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14667793 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07620950 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05233936 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.04866964 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.02560017 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01090435 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00330383 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98240269 |
| 44 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97296415 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.97077223 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.94440304 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94102243 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.92851014 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90882866 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90152892 |
| 51 | * Hepatitis C_Homo sapiens_hsa05160 | 0.89044755 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.89026977 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 0.88767625 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87766515 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.86603470 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85251231 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84087662 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83500406 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82686398 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.82416251 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80857178 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80592549 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80092492 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.79194131 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79087465 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78581966 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78385393 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.75889177 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75882140 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74734993 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74579121 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74560094 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.74540707 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72398351 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.72348246 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71579998 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71079982 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69951205 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68576815 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67936631 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67759397 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67460556 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66943386 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66165802 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.64062069 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63086673 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63057013 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62428334 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61170175 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60882298 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60831991 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60601634 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60234261 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60107121 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57991097 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57248512 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55961642 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55720807 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55323087 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55176035 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55059178 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54743162 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54619952 |
| 104 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54256769 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53941017 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53369302 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.53078465 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52949599 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52886941 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52860350 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.52826519 |
| 112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52213508 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51938540 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51875889 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50744707 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50578169 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.48734518 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48555349 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48335678 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.48157631 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47302608 |
| 122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45970188 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43585226 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43500934 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43321331 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42386149 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40870715 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40534189 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38453920 |
| 130 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38086678 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36384477 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.36319262 |

